SNS Diagnostics Limited Annual Report and Financials

SNS Diagnostics Limited Balance Sheet (Rs In Thousands)

SNS Diagnostics Limited Profit & Loss Statement (Rs In Thousand)

SNS Diagnostics Limited Consolidated Cash Flow Statement (Rs In Lakhs)

Certainly, here is a summary of the Cash Flow Statement for the years 2019 and 2018:

1. Profit Before Taxation:

In 2019, the company reported a profit before taxation of Rs -4.66 million, indicating a loss. This was an improvement from the previous year 's figure of Rs -5.62 million, suggesting a narrowing of losses.

2. Adjustments for Interest:

Interest debited during the year amounted to Rs 1.93 million in 2019, showing an increase from the previous year 's Rs 0.94 million. This could be attributed to higher interest expenses, impacting the overall financial performance.

3. Working Capital Changes:

There was an increase in trade and other receivables in 2018, with a specific amount not provided. However, in 2019, there was no specific figure mentioned. The increase in trade payables was Rs 2.49 million in 2019, slightly higher than the previous year 's Rs 2.46 million. These changes in working capital components are crucial for assessing liquidity and operational efficiency.

4. Net Cash from Operating Activities:

The net cash generated from operating activities was Rs -0.25 million in 2019, an improvement from Rs -2.05 million in 2018. This suggests a positive trend in the company 's ability to generate cash from its core business operations.

5. Net Increase in Cash and Cash Equivalents:

The net increase in cash and cash equivalents for the year 2019 was Rs -0.25 million, compared to Rs -2.05 million in 2018. This implies a better cash position or reduced cash outflows during 2019 compared to the previous year.

6. Cash and Cash Equivalents:

The company had cash and cash equivalents of Rs 1.47 million at the beginning of 2019, which decreased to Rs 1.23 million by the end of the period. This indicates a reduction in available cash resources over the year.

In summary, the company experienced improvements in various financial aspects in 2019 compared to 2018, including a reduced loss, better operating cash flow, and a smaller decrease in cash and cash equivalents. However, a detailed analysis of the specific reasons behind these changes would be necessary to gain a comprehensive understanding of the company 's financial performance.

Bellow are the Financial Ratios

Here is a summary of the financial and operational metrics for SNS Diagnostics Limited for the years 2016:

1. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization):

EBITDA is reported at -1,914.61%. A negative EBITDA percentage indicates that the company 's operating expenses and debt obligations exceed its operating income, suggesting financial challenges.

2. Net Worth:

The net worth is reported at 102.98%. A net worth percentage above 100% suggests that the company 's assets exceed its liabilities. However, a detailed analysis is needed to understand the composition of the net worth and its sustainability.

3. Debt/Equity Ratio:

The Debt/Equity Ratio is 2.24, indicating that the company has a higher proportion of debt in its capital structure compared to equity. This could imply increased financial risk and higher interest obligations.

4. Return on Equity (ROE):

The Return on Equity is reported at -170.05%, indicating a negative return. A negative ROE suggests that the company did not generate positive returns for its shareholders during the period.

5. Total Assets:

Total Assets increased by 3.60%. This indicates growth in the company 's asset base. However, the specific composition and nature of these assets are crucial for a comprehensive analysis.

6. Fixed Assets:

Fixed Assets show 0.00%, which might suggest that the company did not invest in tangible long-term assets during the period. Further investigation is needed to understand the capital expenditure strategy.

7. Current Assets:

Current Assets increased by 19.39%, reflecting growth in short-term assets. Understanding the components of current assets would provide insights into the company 's liquidity position.

8. Current Liabilities:

Current Liabilities decreased significantly by -93.89%. This might indicate effective management of short-term obligations, but the reason for such a substantial decrease needs further examination.

9. Trade Receivables:

Trade Receivables show 0.00%, suggesting that the company may not have outstanding receivables during the period.

10. Trade Payables:

Trade Payables show -100.00%, which could imply that the company has cleared all its trade payables, possibly indicating a strong financial position or efficient working capital management.

11. Current Ratio:

The Current Ratio is 0.31, indicating a potential liquidity challenge. A current ratio below 1 suggests that the company may have difficulties meeting its short-term obligations with its current assets.